Showing 231-240 of 354 grants

Title Institution Researcher Program Duration Total Award Amount
Regenerable Reagentless Sensors for Continuous Monitoring of Insulin Northwestern University Shana Kelley Improving Lives 01-March-2026 to 29-February-2028 $348,937.89
PLGA nanoparticle treatment-induced antigen-specific CD4+ regulatory T cell control of effector CD8+ T cell responses in a model of type 1 diabetes Northwestern University Stephen Miller Cures 01-September-2025 to 31-August-2028 $659,990.00
Differential Aptalyzer: a wearable hydrogel microneedle platform for continuous monitoring of C-peptide in vivo New York University Mahla Poudineh Cures 01-November-2026 to 31-October-2029 $997,957.86
GPR75, a novel actor in beta cell regeneration New York Medical College Ercument Dirice Cures 01-April-2022 to 31-March-2027 $750,000.00
Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare Nemours Children’s Clinic Jessica Pierce Improving Lives 01-May-2023 to 30-April-2028 $640,819.87
Evaluating the Impact of High-Risk HLA-DR Serotypes on the Cellular Neighborhood of the Pancreatic Islets: Towards Early Identification of T1D Disease Risk and Prevention Missouri University of Science and Technology Gina Yosten Cures 01-October-2025 to 30-September-2028 $740,097.60
T1D Data Identification Consensus Initiative Milliman Rebecca Smith Cures 15-September-2026 to 31-May-2027 $260,000.00
Multicolor cellular immunoimaging of response to transplanted islet cells Michigan State University Bryan Smith Cures 01-June-2023 to 31-May-2026 $750,000.00
Autoimmune stem-like T cells in type 1 diabetes Memorial Sloan-Kettering Cancer Center Andrea Schietinger Cures 01-September-2023 to 31-August-2026 $750,000.00
Co-engineering stem cell-derived beta cells and regulatory T cells to treat type 1 diabetes Medical University of South Carolina Leonardo Ferreira Cures 01-January-2026 to 31-December-2028 $1,049,999.80